1. Home
  2. NRXP vs FPAY Comparison

NRXP vs FPAY Comparison

Compare NRXP & FPAY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NRXP
  • FPAY
  • Stock Information
  • Founded
  • NRXP 2015
  • FPAY 2003
  • Country
  • NRXP United States
  • FPAY United States
  • Employees
  • NRXP N/A
  • FPAY N/A
  • Industry
  • NRXP Biotechnology: Pharmaceutical Preparations
  • FPAY Diversified Commercial Services
  • Sector
  • NRXP Health Care
  • FPAY Consumer Discretionary
  • Exchange
  • NRXP Nasdaq
  • FPAY Nasdaq
  • Market Cap
  • NRXP 32.6M
  • FPAY 27.2M
  • IPO Year
  • NRXP N/A
  • FPAY N/A
  • Fundamental
  • Price
  • NRXP $3.11
  • FPAY $1.06
  • Analyst Decision
  • NRXP Strong Buy
  • FPAY Strong Buy
  • Analyst Count
  • NRXP 4
  • FPAY 2
  • Target Price
  • NRXP $28.50
  • FPAY $3.25
  • AVG Volume (30 Days)
  • NRXP 193.0K
  • FPAY 86.9K
  • Earning Date
  • NRXP 08-13-2025
  • FPAY 08-05-2025
  • Dividend Yield
  • NRXP N/A
  • FPAY N/A
  • EPS Growth
  • NRXP N/A
  • FPAY N/A
  • EPS
  • NRXP N/A
  • FPAY N/A
  • Revenue
  • NRXP N/A
  • FPAY $139,800,732.00
  • Revenue This Year
  • NRXP N/A
  • FPAY $16.58
  • Revenue Next Year
  • NRXP N/A
  • FPAY N/A
  • P/E Ratio
  • NRXP N/A
  • FPAY N/A
  • Revenue Growth
  • NRXP N/A
  • FPAY 19.51
  • 52 Week Low
  • NRXP $1.10
  • FPAY $0.84
  • 52 Week High
  • NRXP $6.01
  • FPAY $2.37
  • Technical
  • Relative Strength Index (RSI)
  • NRXP 46.78
  • FPAY 37.74
  • Support Level
  • NRXP $3.12
  • FPAY $0.84
  • Resistance Level
  • NRXP $3.53
  • FPAY $1.15
  • Average True Range (ATR)
  • NRXP 0.18
  • FPAY 0.08
  • MACD
  • NRXP -0.05
  • FPAY -0.01
  • Stochastic Oscillator
  • NRXP 16.83
  • FPAY 46.34

About NRXP NRX Pharmaceuticals Inc.

NRX Pharmaceuticals Inc is a clinical-stage, small-molecule pharmaceutical company that develops and plans to distribute novel therapeutics for the treatment of central nervous system disorders and life-threatening pulmonary diseases. It has announced the commercialization of ZYESAMI (Aviptadil), an application for COVID-related respiratory failure. The company is also developing NRX-100/101, the first sequential drug regimen for bipolar depression in patients with acute suicidal ideation and behavior.

About FPAY FlexShopper Inc.

FlexShopper Inc is a financial technology company engaged in providing certain types of durable goods to consumers on a lease-to-own basis and providing lease-to-own (LTO) terms to consumers of third-party retailers and e-tailers. Its products include electronics, computers, furniture, mattresses, cameras and camcorders, audio, musical instruments, health, fitness and sports, video games, homes, gardens and tools, appliances, and vacuums on a payment, lease basis. The firm generates a majority of its revenue by leasing its products. The company enables consumers utilizing its e-commerce marketplace to shop for brand-name electronics, home furnishings, and other durable goods on a lease-to-own (LTO) basis.

Share on Social Networks: